Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermolastin
Scottsdale, Arizona, United Statesdermolastin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dermolastin is a biotechnology company focused on the development of recombinant human elastin for medical and aesthetic applications. The company leverages its proprietary platform to produce bio-identical human elastin, a critical protein responsible for skin elasticity that naturally diminishes with age. Dermolastin's pipeline targets wound healing, scar prevention, and skin rejuvenation. By restoring elastin levels, the company aims to provide therapeutic solutions for dermatological conditions and age-related skin degradation.
- Therapeutic areas
- Dermatology
- Modalities
- Recombinant protein
- Industry
- Biotech
Beyond the preview
Go deeper on Dermolastin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermolastin.